Wei Xiaoyi, Zong Wenjing, Gao Yanbin, Peng Siyang, Liu Ke, Zheng Yalin
Beijing Key Lab of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Evid Based Complement Alternat Med. 2020 Oct 29;2020:3452625. doi: 10.1155/2020/3452625. eCollection 2020.
To determine the effects of TLN on glycolipid metabolism, oxidative stress, and intestinal flora in diabetic rat.
Thirty-five male Sprague-Dawley (SD) rats (180-200 g) were divided into two groups. The normal group was fed a standard-chow diet, whereas, in the model group, diabetes was induced by intraperitoneal administration of streptozotocin (STZ) combined with a high-fat sucrose diet. Then, the model group was randomly allocated to four groups: DM (diabetes model) and TLNH (TLN high dose), TLNL (TLN low dose), and NAC (N-acetylcysteine). Rats in the TLNH, TLNL, and NAC groups were intragastrically administered TLN and NAC for 12 weeks. Subsequently, their weights, fasting glucose levels, serum lipids, serum insulin, serum ROS, and intestinal flora were determined.
The weight and intestinal flora abundance of the DM group were significantly lower than those of the normal group, whereas their total serum cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), serum reactive oxygen species (ROS), and serum insulin (INS) levels were significantly higher than those of the normal group. TC and LDL-C levels in the TLNL group and DM group were similar, whereas FBG, INS, and ROS levels in the TLNL group were obviously lower than those in the DM group. Compared with the DM group, there was a significant increase in intestinal flora abundance in the TLNL group. At the phylum level, the ratio of Firmicutes to Bacteroidetes (core microbiota) varied in all groups. However, in the DM group, Firmicutes abundance decreased, whereas that of Bacteroidetes increased. An opposite trend was observed in the TLN-treated groups.
TLN, which showed a dose-dependent therapeutic effect, can effectively decrease serum lipid, serum insulin, blood glucose, and serum ROS levels. It can also rebalance the ratio of Firmicutes to Bacteroidetes. Furthermore, the low-dose TLN treatment was most efficacious.
确定TLN对糖尿病大鼠糖脂代谢、氧化应激和肠道菌群的影响。
将35只雄性Sprague-Dawley(SD)大鼠(180 - 200克)分为两组。正常组给予标准饲料,而模型组通过腹腔注射链脲佐菌素(STZ)联合高脂蔗糖饮食诱导糖尿病。然后,将模型组随机分为四组:DM(糖尿病模型)组、TLNH(TLN高剂量)组、TLNL(TLN低剂量)组和NAC(N-乙酰半胱氨酸)组。TLNH组、TLNL组和NAC组的大鼠灌胃给予TLN和NAC,持续12周。随后,测定它们的体重、空腹血糖水平、血脂、血清胰岛素、血清活性氧和肠道菌群。
DM组的体重和肠道菌群丰度显著低于正常组,而其血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、血清活性氧(ROS)和血清胰岛素(INS)水平显著高于正常组。TLNL组和DM组的TC和LDL-C水平相似,而TLNL组的空腹血糖(FBG)、INS和ROS水平明显低于DM组。与DM组相比,TLNL组的肠道菌群丰度显著增加。在门水平上,所有组中厚壁菌门与拟杆菌门的比例(核心微生物群)有所不同。然而,在DM组中,厚壁菌门丰度降低,而拟杆菌门丰度增加。在TLN治疗组中观察到相反的趋势。
TLN具有剂量依赖性治疗作用,可有效降低血脂、血清胰岛素、血糖和血清ROS水平。它还可以重新平衡厚壁菌门与拟杆菌门的比例。此外,低剂量TLN治疗效果最佳。